MedTrace Logo

Personalized Neurorehabilitative Precision Medicine - From Data to Therapies

NCT04688970 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-12-30

No results posted yet for this study

Summary

Stroke is the most common neurological disease leaving one third dead and one third with permanent impairment despite best medical treatment. The aim of the present study is to investigate why patients differ in how they benefit from neurorehabilitation by collecting clinical, electrophysiological, imaging and laboratory data in the acute phase of stroke as well as later on during rehabilitation and after 90 days. Following a closed-loop approach the data is analyzed by a machine learning algorithm to create a personalized neurorehabilitation strategy.

Conditions

  • Stroke, Acute
  • Outcome, Improvement
  • Rehabilitation
  • Upper Extremity Paresis

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Interfaculty Institute for Biomedical Informatics (IBMI)

    collaborator UNKNOWN

  • Cluster of Excellence - Machine Learning for Science

    collaborator UNKNOWN

  • Department for diagnostic and interventional neuroradiology, University hospital of Tuebingen

    collaborator UNKNOWN

  • Deparmet of biomedical magnetic resonance, University hospital of Tuebingen

    collaborator UNKNOWN

  • Kliniken Schmieder

    collaborator UNKNOWN

  • SRH-Kliniken

    collaborator UNKNOWN

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Ulf Ziemann, PhD, M. d., Prof. · Head of the department of neurology of the university hospital Tuebingen and Hertie-Institut for clinical brain research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-03-31
Completion
2022-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04688970 on ClinicalTrials.gov